西瓜影音进不去:GMP News: Production of WFI through Membrane ...
来源:百度文库 编辑:九乡新闻网 时间:2024/04/27 15:04:29
GMP News
30/03/2011
Production of WFI through Membrane Processes: Survey Results
The European Pharmacopoeia only allows distillation for the production of Water for Injection (WFI). In the USA, cold production i.e. via membrane processes is also allowed. The discussion of whether to allow cold production of WFI in Europe too has been lasting. The EDQM wants to find out the current state-of-the-art through a survey among the stakeholders and consider a possible change in the European Pharmacopoeia. We have asked the GMP Newsletter's readers if such a change would be interesting for them.
Users of water systems and system suppliers were surveyed separately. Yet, the answers they gave are surprisingly very similar.
Results
The possibility to produce WFI cold via membrane processes is equally interesting for both pharma users and system suppliers. However, more than 90% of the users believe that distillation is still the safest alternative. That's why over 50% of them first want to wait for the results from other pharmaceutical companies. More than 80% think that the international pharmacopeias should also be harmonised before. The harmonisation of the pharmacopoeial requirements is what the system suppliers want too. Most interesting: more than half of the surveyed suppliers don't believe that the alternative production of WFI via membrane processes would reduce the costs for the operators, contrary to what has been thought by the users.
Please also see thecomplete results.
Dr Robert Eicher
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
30/03/2011
Production of WFI through Membrane Processes: Survey Results
The European Pharmacopoeia only allows distillation for the production of Water for Injection (WFI). In the USA, cold production i.e. via membrane processes is also allowed. The discussion of whether to allow cold production of WFI in Europe too has been lasting. The EDQM wants to find out the current state-of-the-art through a survey among the stakeholders and consider a possible change in the European Pharmacopoeia. We have asked the GMP Newsletter's readers if such a change would be interesting for them.
Users of water systems and system suppliers were surveyed separately. Yet, the answers they gave are surprisingly very similar.
Results
The possibility to produce WFI cold via membrane processes is equally interesting for both pharma users and system suppliers. However, more than 90% of the users believe that distillation is still the safest alternative. That's why over 50% of them first want to wait for the results from other pharmaceutical companies. More than 80% think that the international pharmacopeias should also be harmonised before. The harmonisation of the pharmacopoeial requirements is what the system suppliers want too. Most interesting: more than half of the surveyed suppliers don't believe that the alternative production of WFI via membrane processes would reduce the costs for the operators, contrary to what has been thought by the users.
Please also see thecomplete results.
Dr Robert Eicher
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
GMP News: Production of WFI through Membrane ...
GMP News: New Compilation of Community Proced...
GMP News: Extension of the Variations Regulat...
GMP News: Dedicated Facilities: FDA publishes...
GMP News: Video Presentation from FDA′s Dr Mo...
GMP News: New EMA Checklist should help Type ...
Rise of China top news of the century - Peopl...
lean-production
BBC News - Graduates - the new measure of pow...
Giant panda victim of bad weather CCTV News
News
GMP基本知识
GMP培训教材
Break Through
introduce new production
China's filter membrane market | LinkedIn
GMP法规内容
GMP标准_
药品GMP检查指南-
兽药GMP培训教材1
新旧GMP对比
go through的用法
across, along 与 through
China faces challenges in grain production de...